Logo-ipp

Immunopathol Persa. 2021;7(1): e09. doi: 10.34172/ipp.2021.09

Original

Evaluation of the feasibility of using weekly paclitaxel as neoadjuvant therapy in patients with epithelial ovarian cancer; a pre-post clinical trial

Sakineh Ebrahimi 1 ORCID, Seyed Saeed Hashemi Nazari 2 ORCID, Arash Dooghaie Moghadam 2 ORCID, Shirin Haghighi 3 * ORCID

Cited by CrossRef: 1

1- Zhang X, Guan G, Wang Z, Lv L, Chávez-Madero C, Chen M, Yan Z, Yan S, Wang L, Li Q. Drug release evaluation of Paclitaxel/Poly-L-Lactic acid nanoparticles based on a microfluidic chip. Biomed Microdevices. 2021;23(4) [Crossref]